Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Cardiff Oncology, Inc. (TROV)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Total revenues   [+]  0.40.40.40.30.40.4
            Revenue growth    -2.8%-2.4%-1.9%1.6%54.7%47.6%
Cost of goods sold    0.00.00.00.00.00.0
Gross profit    0.40.40.40.30.40.4
            Gross margin    100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]  13.813.511.811.410.19.0
Research and development    24.621.317.414.813.511.8
EBITDA   [+]  -37.7-34.1-28.4-25.4-22.7-19.9
            EBITDA margin    -9830.5%-9452.6%-7912.0%-7353.9%-5754.7%-5388.6%
Depreciation and amortization    0.30.40.50.50.50.5
EBIT   [+]  -38.0-34.5-28.9-25.8-23.2-20.4
            EBIT margin    -9906.5%-9553.2%-8037.6%-7485.8%-5871.1%-5514.6%
Interest income    0.50.40.30.20.20.1
Other income (expense), net   [+]  -0.30.00.30.20.0-0.1
Pre-tax income    -37.8-34.1-28.3-25.4-23.0-20.4
Income taxes    0.00.00.00.00.00.0
            Tax rate    0.0%0.0%0.0%0.0%0.0%0.0%
Net income    -37.8-34.1-28.3-25.5-23.1-23.7
            Net margin    -9847.7%-9454.0%-7887.2%-7382.6%-5836.5%-6402.2%
   
Basic EPS   [+]  ($0.92)($0.85)($0.73)($0.75)($0.77)($0.99)
Diluted EPS   [+]  ($0.92)($0.85)($0.73)($0.75)($0.77)($0.99)
   
Shares outstanding (basic)   [+]  41.340.138.634.130.024.0
Shares outstanding (diluted)   [+]  41.340.138.634.130.024.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy